Curing cancer — child's play
Author: Catherine H Cole
Published online: 15 June 2015
To the Editor: Last week, a close friend began chemotherapy for breast cancer, and this week, my husband is having a radical prostatectomy for prostate cancer. Hardly surprising, given our age and that these are the commonest cancers of women and men. However, it is surprising that despite them both being treated by the best oncology specialists, neither is enrolled in a clinical trial.
It seems that clinical trials in these diseases are more common for recurrent or metastatic disease and are usually drug company trials aimed at marketing new and expensive drugs for patients with incurable cancer. Indeed, the availability of targeted therapies has transformed many incurable cancers into chronic diseases, but the costs threaten to break the health budget.
A simple way to reduce these costs is to cure patients when they present with de novo disease. Improving the cure rate is achieved by enrolling patients in clinical trials. Until cancer has 100% cure without toxicity, there is always a question to be asked by means of a randomised controlled trial. These trials may or may not include new drugs and interactions with industry (at arm's length to avoid any real or perceived conflicts of interest).
I am describing embedded clinical research in all cancer treatment centres aimed at continual improvement in outcomes. Research in such centres is performed by committed oncologists (including surgeons, radiation oncologists and the entire multidisciplinary team) setting aside the time to take part in cooperative group trials. The cooperative groups require minimal funding, as most of the costs of cancer treatment are being incurred whether or not the patient is in a trial. However, they do need government commitment and hospital administrative support for data management and statistical analysis.
To see an example of how this system works in practice, look no further than the paediatric oncologists who have worked collaboratively for half a century, enrolling patients in embedded clinical trials, and are now curing over 80% of children with cancer.1,2
Competing interests
No relevant disclosures.
References
- Evans AE. Pediatric cancer treatment: a model for oncology. Am J Roentgenol 1976: 127: 891-895. _Ref419485823
- Cole CH. Lessons from fifty years curing childhood leukemia. J Paed Child Health 2015; 51: 78-81. _Ref419485825
Challenges and Opportunities for Strong and Dynamic Foundations in the Australian Cancer Plan
Ashley M. Hopkins, Andrew Rowland, Natansh D. Modi, Ceara Rickard, Mark Haseloff, Norma B. Bulamu, Imogen Ramsey, Niranjan Bidargaddi, Ganessan Kichenadasse, Michael J. Sorich, Kalinda E. Griffiths, Aideen McInerney-Leo, David M. Roder, Raymond J. Chan
Opportunities and Challenges to Achieving the Australian Cancer Plan Goal of World Class Health Systems for Optimal Cancer Care
Carolyn Ee, Ria Joseph, Elise Button, Stacey George, Makala Castelli, David Currow, Prue Cormie, Olivia Farrer, Michael Jefford, Nicolas H. Hart, Chad Y. Han, Deidre D. Morgan, Michael P. Osborn, Candice Oster, Joel Rhee, Anna Ugalde, Eric Yeung, Catherine Paterson
Maximising Cancer Prevention and Early Detection in the Australian Cancer Plan: Where Are We Now and What Should Come Next?
Erin L. Symonds, Billie Bonevski, Richard Edwards, Nathan J. Harrison, Sana Ishaque, Nicole M. Rankin, Sibel Saya, Renee J. Smith, Carolyn Ee
An Australian Narrative Review of Adoptive Cellular Therapies in Malignancy: Expanding Indications, Referral Pathways and Safety Beyond Specialist Centres
Sarah Childs, David Ma, Anthony Rodrigues, Jennifer Massey, Rasha Cosman, Venessa Chin, Laila Girgis, James Lynam, Peter Lau, Barbara Withers, Anthony M. Joshua, Ben Tran, Jayesh Desai, Simon J. Harrison, John Moore, Jia Liu
Peritoneal Tuberculosis and Chronic Myeloid Leukaemia: A Case of Hickam's Dictum
Zayn Al-Timimi, Gem Chew, Martin Browne, Christiaan Mostert
From Ambition to Action: Closing Policy, Equity and Implementation Gaps in the Australian Cancer Plan's ‘Enhanced Consumer Experience’
Carla Thamm, Elise Button, Oluwaseyifunmi A. Agbejule, Reegan Knowles, Karen van Gorp, Mark B. Pinkham, Meinir Krishnasamy, Alexandra L. McCarthy, Raymond J. Chan